In contrast to vaccination with acellular pertussis vaccines, nasal administration of BPZE1 protects mice against nasal as well as lung colonization by virulent B. pertussis, and BPZE1-induced protection in the nose was strongly diminished in IgA-deficient mice (27). Here, CD79A is linked to pertussis.